Epigenetic alterations in the multifaceted inhibitory effects of metformin on castration resistant prostate cancer

被引：1
|
作者：
Li, Xin [1 ]
Wei, Juncheng [1 ]
Matsumura, Satoko [1 ]
Guo, Yuqi [1 ]
Yuan, Huawei [1 ]
机构：
[1] NYU, New York, NY USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4033
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Castration Resistant Prostate Cancer 2011
    Miller, K.
    AKTUELLE UROLOGIE, 2011, 42 (02) : 95 - 102
  • [22] Exploiting Epigenetic Alterations in Prostate Cancer
    Baumgart, Simon J.
    Haendler, Bernard
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
  • [23] QUANTIFICATION OF EPIGENETIC ALTERATIONS IN PROSTATE CANCER
    Stadler, T. C.
    Jung, A.
    Schlenker, B.
    Boulesteix, A. L.
    Bernau, C.
    Buchner, A.
    Kirchner, T.
    Stief, C. G.
    Bastian, P. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 171 - 171
  • [24] Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer
    Babcook, Melissa A.
    Shukla, Sanjeev
    Fu, Pingfu
    Vazquez, Edwin J.
    Puchowicz, Michelle A.
    Molter, Joseph P.
    Oak, Christine Z.
    MacLennan, Gregory T.
    Flask, Chris A.
    Lindner, Daniel J.
    Parker, Yvonne
    Daneshgari, Firouz
    Gupta, Sanjay
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (10) : 2288 - 2302
  • [25] Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Agarwal, Neeraj
    Pond, Gregory Russell
    Nagy, Rebecca J.
    Nussenzveig, Roberto H.
    Hahn, Andrew W.
    Sartor, Oliver
    Gourdin, Theodore Stewart
    Nandagopal, Lakshminarayanan
    Ledet, Elisa M.
    Naik, Gurudatta
    Armstrong, Andrew J.
    Wang, Jue
    Bilen, Mehmet Asim
    Gupta, Shilpa
    Grivas, Petros
    Pal, Sumanta K.
    Lanman, Richard B.
    Talasaz, AmirAli
    Lilly, Michael B.
    CANCER, 2019, 125 (09) : 1459 - 1469
  • [26] Alterations of androgen action in castration-resistant prostate cancer (CRPC) and in abnormalities of virilization
    McPhaul, Michael J.
    Malewska, Alicia
    Vilaythong, Jill
    Glickman, Stephen E.
    Marcelli, Marco
    Sharifi, Nima
    Auchus, Richard J.
    ENDOCRINE JOURNAL, 2010, 57 : S264 - S264
  • [27] DIETHYLSTILBESTROL IN CASTRATION-RESISTANT PROSTATE CANCER OESTROGENS IN CASTRATION-RESISTANT PROSTATE CANCER: BACK TO THE FUTURE?
    Sartor, Oliver
    BJU INTERNATIONAL, 2012, 110 (11B) : E736 - E736
  • [28] BET bromodomain inhibitors-A novel epigenetic approach in castration-resistant prostate cancer
    Lochrin, Sarah E.
    Price, Douglas K.
    Figg, William D.
    CANCER BIOLOGY & THERAPY, 2014, 15 (12) : 1583 - 1585
  • [29] The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer
    Mayer, Michelle J.
    Klotz, Laurence H.
    Venkateswaran, Vasundara
    JOURNAL OF UROLOGY, 2017, 197 (04): : 1068 - 1074
  • [30] Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells
    Emuejevoke Olokpa
    Sammed N. Mandape
    Siddharth Pratap
    La Monica V. Stewart
    BMC Cancer, 22
12345